Page Industries gets WRAP recertification; surges more than 9 per cent
Page Industries gets WRAP recertification; surges more than 9 per cent

Page Industries gets WRAP recertification; surges more than 9 per cent

Deepti Shidore Article rating: 3.8

Page Industries has an exclusive licence of Jockey International Inc. for manufacturing, distribution & marketing its products in India, Bangladesh, Omar, Qatar, Sri Lanka, Nepal, Maldives, Bhutan, and UAE as well as of Speedo International Ltd but only in India. 

Natco Pharma introduces anti-blood clot tablet in India
Natco Pharma introduces anti-blood clot tablet in India

Natco Pharma introduces anti-blood clot tablet in India

Ganesh V Article rating: 2.8

Natco Pharma today announced the launch of the Rivaroxaban molecule, under the brand RPIGAT. Rivaroxaban is an anticoagulant medication, which is used to treat as well as prevent blood clots.

Five stocks with buying interest
Five stocks with buying interest

Five stocks with buying interest

Ganesh Pawar Article rating: 3.2

The market opened in green on December 17, 2020, overall volumes in futures & options currently stand at 3,01,10,678 contracts with a turnover of Rs. 25,87,753.33 crore.

Five stocks with selling interest
Five stocks with selling interest

Five stocks with selling interest

Ganesh Pawar Article rating: 3.2

The market opened in green on December 17, 2020, overall volumes in futures & options currently stand at 3,01,10,678 contracts with a turnover of Rs. 25,87,753.33 crore.

Stocks witnessing selling pressure in November 2020
Stocks witnessing selling pressure in November 2020

Stocks witnessing selling pressure in November 2020

Henil Shah Article rating: 4.1

As every coin has a flip side, mutual funds are no different in that sense. Fund managers not only buy but also sell. It becomes equally important to know what they are selling. So, let’s find out.

Lupin settles Gavis/Novel dispute on a friendly note
Lupin settles Gavis/Novel dispute on a friendly note

Lupin settles Gavis/Novel dispute on a friendly note

Shreya Chaware Article rating: 4.7

Lupin has officially announced that the dispute with the sellers of Gavis Pharmaceuticals and Novel Laboratories regarding the breaching of the terms of purchase & sales agreement of the definitive agreement entered in 2015 by the company has now been resolved on a friendly note.

RSS
First18981899190019011903190519061907Last

DALAL STREET INVESTMENT JOURNAL - DEMOCRATIZING WEALTH CREATION

Principal Officer: Mr. Shashikant Singh,
Email: principalofficer@dsij.in
Tel: (+91)-20-66663800

Compliance Officer: Mr. Rajesh Padode
Email: complianceofficer@dsij.in
Tel: (+91)-20-66663800

Grievance Officer: Mr. Rajesh Padode
Email: service@dsij.in
Tel: (+91)-20-66663800

Corresponding SEBI regional/local office address- SEBI Bhavan BKC, Plot No.C4-A, 'G' Block, Bandra-Kurla Complex, Bandra (East), Mumbai - 400051, Maharashtra.
Tel: +91-22-26449000 / 40459000 | Fax : +91-22-26449019-22 / 40459019-22 | E-mail : sebi@sebi.gov.in | Toll Free Investor Helpline: 1800 22 7575 | SEBI SCORES | SMARTODR